China's MOH To Enforce Medical Appointment In Public Hospitals
This article was originally published in PharmAsia News
Executive Summary
China's Ministry of Health has released an opinion draft on enforcing medical appointments in public hospitals for public feedback. The document proposes that all Class III hospitals should start medical appointment service from this October, and the policy will be gradually implemented by Class II hospitals. To provide patients with the service, healthcare institutions can set up special facilities, information desks and service windows in outpatient hall; they can also set up direct telephone lines and mobile phones, as well as take advantage of the 12310 hotline or the Internet. Meanwhile, MOH encourages health administrations from regions with suitable conditions to explore having hospitals jointly establish an online registration or appointment platform. (Click here for more - Chinese Language)
You may also be interested in...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.